YOLFTbeta
Intervacc AB

Intervacc AB

IVACC · ST · Healthcare / Biotechnology

0.674SEK-0.02 (-3.30%)

Price History

Full chart

Market Stats

Previous Close0.697
Open0.686
Day Range0.645 – 0.73
52-Week Range0.572 – 1.46
Volume1.37M
Market Cap330.93M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.27
Dividend Yield0.00%
Beta0.15
50-Day Avg1.11
200-Day Avg1.04

About

Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Strangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against streptococcus suis for the treatment of weaned piglets; and INV412, a multi-component vaccine to protect against several bacteria which cause mastitis for treating cows. It also engages in marketing and distribution of veterinary products in the Nordic markets, which includes vaccines and pharmaceuticals for swine, horses, cattle, and sheep. The company was incorporated in 1983 and is based in Hägersten, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Carl-Johan Dalsgaard M.D., Ph.D.
  • Employees16
  • HeadquartersVästertorpsvägen 135, Hägersten, Sweden, 129 44, Sweden
  • Websitehttps://intervacc.se

Leadership

  • Dr. Carl-Johan Dalsgaard M.D., Ph.D.Chief Executive Officer · b. 1956
  • Mr. Jan PerssonChief Financial Officer
  • Mr. Lars StubberudChief Technology Officer · b. 1964
  • Dr. Andrew WallerChief Scientific Officer
  • Ms. Anna-Carin LagerlofSales & Marketing Director

Financials

Income Statement

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue794.40K78.09M62.83M55.58M48.00M35.60M12.14M4.78M5.24M9.68M8.02M11.79M20.09M
Growth (%)-+9729.64%-19.54%-11.55%-13.62%-25.84%-65.90%-60.62%+9.64%+84.77%-17.23%+47.06%+70.42%
Cost of Revenue-41.94M34.28M38.62M32.73M28.09M9.26M137.00K-1.00M6.32M21.82M15.31M87.50M
Gross Profit794.40K36.15M28.55M16.96M15.27M7.51M2.88M4.64M6.25M3.37M-13.81M-3.53M-67.41M
Gross Margin100.00%46.30%45.44%30.52%31.81%21.08%23.72%97.13%119.18%34.77%-172.25%-29.92%-335.60%
Operating Expense3.24M26.04M26.47M24.36M28.95M38.42M30.73M30.32M35.64M67.78M79.77M73.75M17.45M
Operating Income-2.45M10.11M2.08M-7.40M-13.68M-30.92M-27.85M-25.68M-29.39M-64.41M-93.58M-77.28M-84.86M
Operating Margin-308.39%12.95%3.31%-13.31%-28.50%-86.85%-229.41%-537.15%-560.83%-665.15%-1167.55%-655.61%-422.45%
EBITDA-2.45M16.43M8.50M-785.08K-7.18M-16.15M-21.69M-19.39M-23.15M-57.73M-68.98M-58.75M-66.25M
EBITDA Margin-308.20%21.04%13.52%-1.41%-14.95%-45.38%-178.66%-405.71%-441.69%-596.12%-860.64%-498.41%-329.81%
Net Income-2.29M9.32M138.08K-6.81M-12.77M-27.49M-27.89M-25.60M-29.38M-64.16M-102.85M-75.52M-80.81M
Net Income Margin-287.65%11.94%0.22%-12.25%-26.59%-77.22%-229.77%-535.59%-560.48%-662.52%-1283.24%-640.66%-402.32%
R&D-----8.36M---14.56M17.55M17.33M-
R&D as % of Total Revenue-----23.49%---150.31%218.90%147.03%-
Interest Expense-515.52K830.35K853.91K448.22K131.00K44.00K33.00K74.00K125.00K133.00K130.00K13.00K
Interest Expense % of Total Revenue-0.66%1.32%1.54%0.93%0.37%0.36%0.69%1.41%1.29%1.66%1.10%0.06%

Balance Sheet

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets52.63M154.92M154.96M163.66M179.64M202.66M237.07M355.28M329.39M265.04M259.61M187.32M294.43M
Total Liabilities1.24M52.74M28.44M33.47M14.74M12.23M17.25M17.67M21.14M14.88M21.68M24.99M19.52M
Total Equity51.39M102.18M126.52M130.18M164.90M190.43M219.82M337.61M308.25M250.16M237.93M162.33M274.91M
Cash3.59M20.17M12.59M13.26M21.50M36.51M52.54M164.25M115.71M45.70M88.34M34.40M160.89M
Total Debt-18.89M18.25M23.85M8.55M1.06M744.00K383.00K433.00K322.00K181.00K145.00K108.00K
Net Debt-3.59M-1.29M5.66M10.58M-12.95M-35.44M-51.80M-163.87M-115.28M-45.38M-88.16M-34.40M-160.78M

Cash Flow

Currency: SEK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---19.09M-4.20M-19.16M-4.03M-2.77M-20.08M-25.46M-69.79M-45.83M-53.20M-65.79M
Investing Cash Flow---10.48M-9.61M-12.51M-23.34M-38.96M-11.27M-23.13M-6.13M-2.11M-706.00K-1.13M
Financing Cash Flow--23.10M14.48M39.91M42.39M57.77M143.06M50.00K5.91M90.58M-36.00K193.40M
Capital Expenditure0010.90M12.13M13.17M24.38M39.50M11.42M23.21M6.13M2.11M706.00K1.13M
Free Cash Flow---29.99M-16.33M-32.33M-28.41M-42.27M-31.50M-48.67M-75.92M-47.94M-53.90M-66.92M
FCF to OCF--157.12%388.76%168.75%704.44%1526.03%156.86%191.14%108.79%104.60%101.33%101.72%

Earnings

Report DateAug 28, 2017Nov 27, 2017Feb 15, 2018May 25, 2018Aug 30, 2018Nov 29, 2018Feb 22, 2019May 29, 2019Aug 30, 2019Nov 28, 2019Feb 21, 2020May 14, 2020Aug 27, 2020Nov 12, 2020Feb 18, 2021May 21, 2021Aug 31, 2021Nov 11, 2021Feb 18, 2022May 20, 2022Aug 31, 2022Nov 10, 2022Feb 17, 2023May 3, 2023Aug 31, 2023Nov 16, 2023Feb 16, 2024May 15, 2024Aug 29, 2024Nov 14, 2024Feb 13, 2025May 14, 2025Aug 29, 2025Nov 19, 2025Feb 17, 2026May 13, 2026Aug 20, 2026Nov 12, 2026
EPS Estimate-0.220.16-0.36-0.34-0.06-0.17-0.17-------0.28-0.32-0.30-0.36--0.20------------0.22-0.22-0.23-0.18-0.20-0.06-0.05-0.06
EPS Actual-0.14-0.14-0.41-0.27-0.36-0.14-0.19-0.14-0.22-0.16-0.18-0.15-0.13-0.13-0.14-0.13-0.12-0.17-0.17-0.21-0.31-0.29-0.46-0.30-0.32-0.63-0.26-0.23-0.24-0.29-0.24-0.08-0.05-0.04-0.05-0.06-0.06-
Surprise36.36%-187.50%-13.89%20.59%-500.00%17.65%-11.76%------53.57%56.25%56.67%66.67%-15.00%------------9.09%63.64%78.26%76.67%75.00%0.00%-20.00%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap330.93M
Enterprise Value169.81M
Trailing P/E0.00
Forward P/E0.00
Price / Sales18.27
Price / Book1.42
EPS-0.27
Book Value0.684
Revenue (TTM)18.11M
Gross Profit (TTM)-11.64M
EBITDA-75.48M
Profit Margin0.00%
Operating Margin-329.85%
Return on Equity-32.89%
Return on Assets-18.72%
Shares Outstanding340.81M
Shares Float196.21M
Beta0.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%